HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Review article: faecal transplantation therapy for gastrointestinal disease.

AbstractBACKGROUND:
Evidence is emerging regarding the relationship between a dysbiosis of the human gut microbiota and a number of gastrointestinal diseases as well as diseases beyond the gut. Probiotics have been investigated in many gastrointestinal disease states, with variable and often modest outcomes. Faecal transplantation is an alternative approach to manipulate the gut microbiota.
AIM:
To review the use of faecal transplantation therapy for the management of gastrointestinal disorders.
METHODS:
Available articles on faecal transplantation in the management of gastrointestinal disorders were identified using a Pubmed search and bibliographies of review articles on the subject were collated.
RESULTS:
A total of 239 patients who had undergone faecal transplantation were reported. Seventeen of 22 studies of faecal transplantation were in fulminant or refractory Clostridium difficile. Studies of faecal transplantation are heterogeneous regarding the patients, donors, screening, methods of administration and definition of response. Faecal transplantation for C. difficile has been demonstrated to be effective in 145/166 (87%) patients. Small numbers of patients are reported to have undergone successful faecal transplantation for irritable bowel syndrome and inflammatory bowel disease.
CONCLUSIONS:
Faecal transplantation has been reported with good outcomes for fulminant and refractory C. difficile. No adverse effects of faecal transplantation have been reported. However, there are no level 1 data of faecal transplantation and reports to date may suffer from reporting bias of positive outcomes and under-reporting of adverse effects. This therapy holds great promise, where a dysbiosis of the gut microbiota is responsible for disease and further studies are necessary to explore this potential.
AuthorsJ Landy, H O Al-Hassi, S D McLaughlin, A W Walker, P J Ciclitira, R J Nicholls, S K Clark, A L Hart
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 34 Issue 4 Pg. 409-15 (Aug 2011) ISSN: 1365-2036 [Electronic] England
PMID21682755 (Publication Type: Journal Article, Review)
Copyright© 2011 Blackwell Publishing Ltd.
Topics
  • Bacterial Physiological Phenomena
  • Feces (microbiology)
  • Gastrointestinal Diseases (therapy)
  • Gastrointestinal Tract (microbiology)
  • Humans
  • Microbial Interactions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: